HEALTHCARE NEWS SECRETS

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but The federal government won’t be purchasing it soon after an independent watchdog agency reported the cure isn’t well worth the Price to taxpayersWeather alter, civil conflict and developing resistance to insecticides and solutions are all contributing to an ala